On June 1-2 2017 at the “Cité des Congrès” will be held the “Immunotherapies in transplantation and cancer congress”. It will be the 22nd edition of this event and is the 2nd joint Labex IGO meeting of the “Nantes Actualités Transplantation” (NAT).
This edition will focus on the mechanisms that control immune responses in organ or bone marrow transplantation and in cancer. These mechanisms usually involve the same molecules or cells but have opposite effects in transplantation and in cancer. A given molecule that inhibits immune responses needs to be increased in transplantation to favor immune tolerance and better graft outcome whereas it needs to be inhibited or neutralized in the cancer setting to favor cancer elimination.
This congress is organized in 4 sessions:
- Session 1: Tumor and graft microenvironment
- Session 2: Immune chekpoints
- Session 3: Macrophages and dendritic cells
- Session 4: T cell therapy